Policy | May 29, 2023
We need to focus on quality and affordable manufacturing: Mandaviya
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
The product is expected to be launched in June 2023
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
Product deliveries scheduled in Q3 of 2023
Continues to Expand its Presence in South India
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Subscribe To Our Newsletter & Stay Updated
